Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fludroxycortide 4micrograms/square cm tape 7.5cm
1304000T0AACCCC
|
Fludroxycortide | Fludroxycortide | Skin | 16,472 |
|
Oilatum Emollient
1302011L0BKAEAI
|
Oilatum | Light liquid paraffin | Skin | 16,468 |
|
Pimecrolimus 1% cream
1305030B0AAAAAA
|
Pimecrolimus | Pimecrolimus | Skin | 16,338 |
|
Sebco ointment
1305020V0BCAAAA
|
Sebco | Cocois | Skin | 16,155 |
|
Doublebase Dayleve gel
130201000BBLACA
|
Proprietary compound emollients | Other emollient preparations | Skin | 16,088 |
|
Neutrogena T/Gel Therapeutic shampoo
1309000C0BJAAAN
|
T/Gel Neutrogena | Coal tar | Skin | 16,038 |
|
Crotamiton 10% cream
1303000I0AAAAAA
|
Crotamiton | Crotamiton | Skin | 15,941 |
|
Rozex 0.75% gel
1310012K0BDAAAR
|
Rozex | Metronidazole | Skin | 15,822 |
|
Dovonex 50micrograms/g ointment
1305020D0BBAAAA
|
Dovonex | Calcipotriol | Skin | 15,600 |
|
Isopropyl myristate 15% / Liquid paraffin 15% gel
130201000AACACA
|
Generic compound emollients | Other emollient preparations | Skin | 15,196 |
|
Eurax 10% cream
1303000I0BBABAA
|
Eurax (Topical Local Antipruritic) | Crotamiton | Skin | 14,986 |
|
Emulsifying ointment
1302010F0AAADAD
|
Emulsifying wax (Emollient) | Emulsifying wax | Skin | 14,546 |
|
Dermax Therapeutic 0.5% shampoo
1309000L0BCAAAB
|
Dermax | Benzalkonium chloride | Skin | 14,402 |
|
Betnovate RD 0.025% ointment
1304000F0BBAHBB
|
Betnovate (Topical) | Betamethasone valerate | Skin | 14,324 |
|
Betnovate 0.1% scalp application
1304000F0BBAJBD
|
Betnovate (Topical) | Betamethasone valerate | Skin | 14,118 |
|
Oilatum Plus bath additive
1302011L0BEAAAD
|
Oilatum Plus | Light liquid paraffin | Skin | 13,877 |
|
Clotrimazole 1% solution
1310020H0AAAAAA
|
Clotrimazole (Topical) | Clotrimazole | Skin | 13,686 |
|
Clobetasol 0.05% scalp application
1304000G0AABBBB
|
Clobetasol propionate | Clobetasol propionate | Skin | 12,947 |
|
Clindamycin 1% aqueous lotion
1306010F0AAABAB
|
Clindamycin phosphate (Topical) | Clindamycin phosphate | Skin | 12,813 |
|
Diprobase ointment
130201000BBAEA3
|
Proprietary compound emollients | Other emollient preparations | Skin | 12,648 |
|
Adapalene 0.3% / Benzoyl peroxide 2.5% gel
1306010Z0AAABAB
|
Adapalene/benzoyl peroxide | Adapalene and benzoyl peroxide | Skin | 12,576 |
|
Etrivex 500micrograms/g shampoo
1304000G0BEAACD
|
Etrivex | Clobetasol propionate | Skin | 12,110 |
|
Aveeno lotion
130201000BBJMCB
|
Proprietary compound emollients | Other emollient preparations | Skin | 11,965 |
|
Alphosyl 2 in 1 shampoo
1309000C0BGACAT
|
Alphosyl (Scalp) | Coal tar | Skin | 11,715 |
|
E45 lotion
130201000BBAUA0
|
Proprietary compound emollients | Other emollient preparations | Skin | 11,628 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.